Rezolute RZLT
NASDAQ RZLT
$4.58 +0.04 (+0.88%)
As of: Sep 4, 2026 · 3:59 PM EDT

Rezolute (RZLT) Asset Writedowns and Impairment (2018 - 2020)

Rezolute (RZLT) posted Asset Writedowns and Impairment of $23000.0 for Q2 2020, up 91.67% sequentially from $12000.0 in Q2 2019, and up 91.67% YoY from $12000.0 in Q3 2019.

Analysis

Rezolute (RZLT) Asset Writedowns and Impairment (2018 - 2020) Analysis & Trends

Rezolute has reported Asset Writedowns and Impairment for 3 years, with the latest figure at $23000.0 in Q2 2020.

  • Quarterly Asset Writedowns and Impairment rose 91.67% year-over-year to $23000.0 in Q2 2020, while the trailing twelve-month figure through Jun 2020 was $35000.0 (down 97.98% YoY) and the FY2020 annual result came in at $23000.0, down 48.89% from the prior year.
  • Asset Writedowns and Impairment grew to $23000.0 in Q2 2020 per RZLT's latest filing, from $12000.0 in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $1.7 million in Q2 2018 and troughed at $12000.0 in Q2 2019.
  • A 3-year average of $439750.0 and a median of $28000.0 in 2018 frame the typical range for Asset Writedowns and Impairment.
  • The sharpest annual moves came in 2019 and 2020: Asset Writedowns and Impairment sank 99.29% in 2019, then soared 91.67% in 2020.
  • Over 3 years, Asset Writedowns and Impairment stood at $33000.0 in 2018, then plunged by 63.64% to $12000.0 in 2019, then surged by 91.67% to $23000.0 in 2020.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $23000.0, $12000.0, and $33000.0 for Q2 2020, Q2 2019, and Q4 2018 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Rezolute 477.02 Mn 477.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 23,000.00
Jun 30, 2019 12,000.00
Dec 31, 2018 33,000.00
Jun 30, 2018 1.69 Mn